In this part 2, Kirsten Axelsen, MS, discusses racial disparities, AI in prior authorization, and payers’ readiness for the next wave of CLL therapies.
|Articles|June 4, 2012
Beckie Fenrick, PharmD, MBA, Points to the Trends in Specialty Pharmacy Management
Dr. Fenrick discusses the current and forthcoming trends in specialty pharmacy management.
Advertisement
Beckie Fenrick, PharmD, MDA, Senior Director, Medical Operations, Care Models and Affordability Solutions, Florida Blue, states that a trend in specialty pharmacy is the increase of companion diagnostics and personalized care, which helps to identify the appropriateness of various treatments for specific patients/members.
Advertisement
Related to this article
Kirsten Axelsen, MS, discusses gaps in biomarker testing, nonmedical barriers, and utilization management from a new report on access to CLL care.
In this Q&A, Christie Ballantyne, MD, explains why consistent LDL-C lowering with oral enlicitide could expand PCSK9 use in primary prevention.
Advertisement
Advertisement
Trending on AJMC
1
Real-World Cohort Ties JAK Inhibitors in Alopecia Areata to Menstrual Side Effects
2
Phase 3 Trial Tests Ensifentrine for COPD Exacerbation Prevention
3
Trends in Pharmacy Benefit Manager Market Dynamics, 2016-2025
4
The Liver Meeting 2026 Highlights Hepatitis Delta, PBC Targets, MASH Costs
5